HomeATXS • NASDAQ
add
Astria Therapeutics Inc
Previous close
$11.76
Day range
$11.50 - $11.95
Year range
$4.26 - $16.90
Market cap
651.15M USD
Avg Volume
388.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 28.80M | 90.72% |
Net income | -24.17M | -92.36% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 354.70M | 74.77% |
Total assets | 367.99M | 77.73% |
Total liabilities | 20.91M | 214.42% |
Total equity | 347.08M | — |
Shares outstanding | 56.43M | — |
Price to book | 2.57 | — |
Return on assets | -19.28% | — |
Return on capital | -19.98% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -24.17M | -92.36% |
Cash from operations | -16.79M | -56.98% |
Cash from investing | -68.10M | -17.58% |
Cash from financing | 94.00K | -65.57% |
Net change in cash | -84.80M | -24.08% |
Free cash flow | -12.66M | -42.96% |
About
Founded
2008
Headquarters
Website
Employees
59